IGHE and osteoarthritis: Here, we demonstrate that pharmacologic depletion of IgE, or blockade of IgE-mediated FcεRI signaling using a Syk inhibitor, reduce bone remodeling (as measured by osteophyte formation) and disease severity in the DMM murine model of osteoarthritis.